GB1257162A - - Google Patents

Info

Publication number
GB1257162A
GB1257162A GB1257162DA GB1257162A GB 1257162 A GB1257162 A GB 1257162A GB 1257162D A GB1257162D A GB 1257162DA GB 1257162 A GB1257162 A GB 1257162A
Authority
GB
United Kingdom
Prior art keywords
bis
chain
group
substituted
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GB1257162A publication Critical patent/GB1257162A/en
Expired legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

1,257,162. Bis-chromones and intermediates. FISONS PHARMACEUTICALS Ltd. 31 Jan., 1969 [16 Feb., 1968 (2)], Nos. 7587/69 and 7589/68. Heading C2C. In a process for preparing compounds (I) and its function derivatives. wherein the pairs A 1 and A 2 on one benzene ring may be the same or different from the pairs A 1 and A 2 on the other benzene ring and each pair is OM and H on -COJ; H and -OCD= CHCOOR<SP>2</SP>; OCOCOR<SP>11</SP> and H or -COCH 3 ; or A 1 and A 2 together form the chains -CO-CH=C(D)-O- or -COCH 2 -CH(D)-O- (where M is H, an alk. metal cation or a lower alkyl group; J is a group CH 3 , OR<SP>2</SP>, CH 2 COD or CH=CHD, R<SP>2</SP> is H or 1-10 C alkyl, D is COOR<SP>2</SP> or a group V convertible thereto and R<SP>11</SP> is OH or a group convertible thereto); X is a carbocyclic or heterocyclic ring, straight or branched, saturated or unsaturated, substituted or unsubstituted hydrocarbon chain which chain may be interrupted by one or more heterocyclic or carbocyclic rings, carbonyl groups, 0, S, substituted S, NH, or substituted NH; P, Q, P<SP>1</SP> and Q<SP>1</SP> may be the same or different and may be H, halogen, alkyl, alkoxy, substituted alkyl or alkoxy, the groups T and T<SP>1</SP> are removed from compounds (II) where T and T<SP>1</SP> are the same or different and are carboxylic or sulphonic acid groups or their functional derivatives, tert.-butyl, allyl or an alpha-unsaturated alkyl group, a protected amino group, halogen, nitro or cyano. Furthermore the process includes the step of converting A 1 and A 2 in compounds where one or neither of the pairs A 1 and A 2 form a chain -CO-CH=C(COOH)-O- or a derivative thereof, into such a chain. T and T<SP>1</SP> may be removed by decarboxylation, treatment with strong acids, hydrolysis and diazotization, heating with steam or water, reduction and diazotization and hydrolysis and decarboxylation according to the value of T and T<SP>1</SP>. A 1 and A 2 may be condensed to form a chain by reaction with a dehydrating agent. The following intermediates are prepared: 1,5 - bis - (3 - hydroxy - 4 - methoxycarbonylphenoxy) pentane, and 1,5-bis-(4-carboxy-3-hydroxyphenoxy) pentane; 1,3-bis-(2-acetyl-3-hydroxy - 6 - iodophenoxy) - 2 - hydroxy propane and 1,3 - bis - (2 - ethoxycarbonyl - 6 - iodochromon - 5 - yloxy) - 2 - hydroxy propane.
GB1257162D 1968-02-16 1968-02-16 Expired GB1257162A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB758768 1968-02-16

Publications (1)

Publication Number Publication Date
GB1257162A true GB1257162A (en) 1971-12-15

Family

ID=9835993

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1257162D Expired GB1257162A (en) 1968-02-16 1968-02-16

Country Status (2)

Country Link
AT (1) AT305981B (en)
GB (1) GB1257162A (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2391618A2 (en) * 2009-01-29 2011-12-07 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
US9855276B2 (en) 2012-10-25 2018-01-02 The General Hospital Corporation Combination therapies for the treatment of Alzheimer's disease and related disorders
US9925282B2 (en) 2009-01-29 2018-03-27 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
US10058530B2 (en) 2012-10-25 2018-08-28 The General Hospital Corporation Combination therapies for the treatment of Alzheimer's disease and related disorders
US10188757B2 (en) 2013-10-22 2019-01-29 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
US10525005B2 (en) 2013-05-23 2020-01-07 The General Hospital Corporation Cromolyn compositions and methods thereof
US10561612B2 (en) 2017-07-20 2020-02-18 The General Hospital Corporation Powdered formulations of cromolyn sodium and ibuprofen
US11291648B2 (en) 2018-07-02 2022-04-05 The General Hospital Corporation Powdered formulations of cromolyn sodium and alpha-lactose
US11679095B2 (en) 2016-08-31 2023-06-20 The General Hospital Corporation Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseases

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10245331B2 (en) 2009-01-29 2019-04-02 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
CN102341391A (en) * 2009-01-29 2012-02-01 通用医疗公司 Cromolyn derivatives and related methods of imaging and treatment
EP2391618A4 (en) * 2009-01-29 2012-07-18 Gen Hospital Corp Cromolyn derivatives and related methods of imaging and treatment
US8617517B2 (en) 2009-01-29 2013-12-31 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
AU2010208136B2 (en) * 2009-01-29 2015-03-05 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
CN102341391B (en) * 2009-01-29 2015-08-19 通用医疗公司 Cromoglycic Acid derivative and the application be prepared in the medicine of picture and treatment
CN105061376A (en) * 2009-01-29 2015-11-18 通用医疗公司 Cromolyn derivatives and related methods of imaging and treatment
EP2391618A2 (en) * 2009-01-29 2011-12-07 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
US11801316B2 (en) 2009-01-29 2023-10-31 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
US10576171B2 (en) 2009-01-29 2020-03-03 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
US9925282B2 (en) 2009-01-29 2018-03-27 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
EP3567033A1 (en) * 2009-01-29 2019-11-13 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
US10251961B2 (en) 2009-01-29 2019-04-09 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
US9855276B2 (en) 2012-10-25 2018-01-02 The General Hospital Corporation Combination therapies for the treatment of Alzheimer's disease and related disorders
US9918992B2 (en) 2012-10-25 2018-03-20 The General Hospital Corporation Combination therapies for the treatment of Alzheimer's disease and related disorders
US10058530B2 (en) 2012-10-25 2018-08-28 The General Hospital Corporation Combination therapies for the treatment of Alzheimer's disease and related disorders
US10398704B2 (en) 2012-10-25 2019-09-03 The General Hospital Corporation Combination therapies for the treatment of Alzheimer's disease and related disorders
US10406164B2 (en) 2012-10-25 2019-09-10 The General Hospital Corporation Combination therapies for the treatment of Alzheimer's disease and related disorders
US10413551B2 (en) 2012-10-25 2019-09-17 The General Hospital Corporation Combination therapies for the treatment of Alzheimer'S disease and related disorders
US9968618B1 (en) 2012-10-25 2018-05-15 The General Hospital Corporation Combination therapies for the treatment of Alzheimer's disease and related disorders
US9913847B2 (en) 2012-10-25 2018-03-13 The General Hospital Corporation Combination therapies for the treatment of alzheimer's disease and related disorders
US11110097B2 (en) 2012-10-25 2021-09-07 The General Hospital Corporation Combination therapies for the treatment of alzheimer's disease and related disorders
US10525005B2 (en) 2013-05-23 2020-01-07 The General Hospital Corporation Cromolyn compositions and methods thereof
US11013686B2 (en) 2013-05-23 2021-05-25 The General Hospital Corporation Cromolyn compositions and methods thereof
US11666669B2 (en) 2013-10-22 2023-06-06 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
US10188757B2 (en) 2013-10-22 2019-01-29 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
US11679095B2 (en) 2016-08-31 2023-06-20 The General Hospital Corporation Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseases
US10561612B2 (en) 2017-07-20 2020-02-18 The General Hospital Corporation Powdered formulations of cromolyn sodium and ibuprofen
US11291648B2 (en) 2018-07-02 2022-04-05 The General Hospital Corporation Powdered formulations of cromolyn sodium and alpha-lactose

Also Published As

Publication number Publication date
AT305981B (en) 1973-03-26

Similar Documents

Publication Publication Date Title
GB1257162A (en)
ES557287A0 (en) A PROCEDURE FOR CLONING IN A VECTOR A SPECIFIC NUCLEIC ACID SEQUENCE
GB1350602A (en) Azo dyestuffs
ES424859A1 (en) Process for the manufacture of 2-arylamino-2-imidazoline derivatives and their salts
GB1130638A (en) Preparation of -‡-cyanoacrylic esters
GB1436089A (en) Process for the preparation of furylbenzimidazoles
GB1430221A (en) Process for recovering resorcinol and hydroquinone in mixture
GB1037378A (en) Improved method for the preparation of substituted oxazole compounds
GB1512919A (en) Process for isolating triarylmethane dyestuffs
IT1058547B (en) Dehydro-linalol cyclisation using polyphosphoric acid - prods. being useful as perfume (intermediates)
Erlanger et al. Phosphorus Pentaoxide as a Reagent in Peptide Synthesis
GB1497217A (en) Process for the preparation of cyanuric acid
GB1536320A (en) Process for the mono-diazotization of aromatic diamines
GB1323157A (en) Waterinsoluble dyestuffs and process for their manufacture
GB1308055A (en) Process for the preparation of nitroximes and nitroketones
GB1389227A (en) Chromone-2-carboxylic acid derivatives methods for their preparation and compositions containing them
GB1491772A (en) Method for purifying 11-cyano-undecanoic acid
GB1256288A (en) Process for recovering methyl methacrylate
ES372901A1 (en) Reaction products of carboxylic acid polymers, alkylenimines and alkylene oxides
GB1204121A (en) Novel bis-chromonyl compounds, their preparation and use
GB1425309A (en) Process for the preparation of 5-nitro-1,4-naphthoquinone
GB1463706A (en) Process for recovering purified 4-hydroxy-2,4,6-trimethyl-2,5- cyclohexadien-1-on
GB1228521A (en)
Baliah et al. Preparation of 1-Methylsulfonyl-4-phenyl-1, 3-butadiene
GB1429697A (en) Method for producing isonitrosomalonic esters

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees